Emerging evidence demonstrates that GLP-1 receptor agonists may provide significant benefits for liver health, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD) and its inflammatory subtype, metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)
3, 3-Diindolylmethane induces ferroptosis by BAP1IP3R axis in BGC-823 gastric cancer cells
Tirzepatide enhances insulin sensitivity, lowers glucagon levels, and reduces post-meal glucose excursions
But there are also questions worth asking before you commit
In addition, as GLP-1 is produced, it sends a message to your brain that youre full, reducing your appetite and your cravings